IIT2019-20-ZUMSTEG-HPVOPC

HPV P16(+) Oropharyngeal - IIT2019-20-ZUMSTEG-HPVOPC

IIT2019-20-ZUMSTEG-HPVOPC

Objective

Phase II Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer

Principal Investigator(s)
Vanessa Dickey, MD
Zachary Zumsteg, MD

Clinical Trial Categories

  • Cedars-Sinai Clinical Trials